Cisplatin resistance induces epithelial to mesenchymal transition and cancer stem cells accumulation in oral carcinoma cell lines

Vol. 1, 2019. - 116380
Pôster
Favorite this paper
How to cite this paper?
Abstract

Cisplatin is the one of the most used therapy in oral cancer, and several patients develop resistance. We established cell lines resistant to cisplatin aiming to understanding biological differences driving the progression of oral cancers after treatment. Two cell lines, CAL27 and SCC9 were assessed to establish cisplatin-resistant cell lines through the exposure to different concentrations and time courses of cisplatin. We demonstrated that cellular proliferation, migration and clonogenic capability increased with the resistance levels. Cisplatin administration had not effect over the viability of resistant cell lines. EMT was observed by loss of E-cadherin, gain of Vimentin and the conversion from a cuboidal-epithelial structure into an elongated mesenchymal shape as evidenced by pan-keratin staining. CSC accumulation increased in resistant cell lines. EMT is relevant to the acquisition and maintenance of CSC and is sufficient to endow differentiated cancer cells with stem cell properties, having implications in tumor progression, aggressiveness and resistance to therapy.

Institutions
  • 1 Biologia Basica e Oral / Universidade de São Paulo / Faculdade de Odontologia de Ribeirão Preto
Track
  • Biochemistry, Molecular Biology and Genetics
Keywords
oral carcinoma
cancer stem cells
cisplatin